Neogen Corporation Asset Turnover Ratio (NEOG), as of first quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Neogen Corporation  (NASDAQ: NEOG)
 

Neogen Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Neogen's asset turnover ratio has remained unchanged compare to previous quarter at 0.26 in the first quarter (Aug 31 2026)

Within sector 8 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the First Quarter 2026 compared to the preceding quarter from 2271 to 2755.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NEOG Asset Turnover Ratio (Aug 31 2026)
I. Quarter		 (May 31 2026)
IV. Quarter		 (Feb 28 2026)
III. Quarter		 (Nov 30 2025)
II. Quarter		 (Aug 31 2025)
I. Quarter
Y / Y Asset Change -1.81 % -1.48 % -16.47 % -17.12 % -25.11 %
Y / Y Revenue Change 6.67 % -0.58 % -4.21 % -2.45 % -3.67 %
Asset Turnover Ratio (TTM) 0.26 0.26 0.26 0.25 0.24
NEOG's Total Ranking # 2755 # 2271 # 2116 # 2468 # 2592
Seq. Asset Change -2.28 % 0.64 % -0.03 % -0.12 % -1.96 %
Seq. Revenue Change -1.17 % 6.89 % -6.09 % 7.52 % -7.88 %



Asset Turnover Ratio Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 9
Healthcare Sector # 400
Overall Market # 2755

Asset Turnover Ratio Statistics
High Average Low
0.78 0.57 0.2
(May 31 2014)   (Aug 31 2024)




NEOG Company Profile • Back to NEOG Efficiency Comparisons • Compare NEOG Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Aug 31 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Aug 31 2026 Assets at quarter ending Aug 31 2026
Msa Safety Inc  0.73 $ 2,015.730  Millions$ 2,749.546  Millions
Adapthealth Corp   0.73 $ 3,152.043  Millions$ 4,320.541  Millions
Neurocrine Biosciences Inc   0.72 $ 3,701.700  Millions$ 5,131.050  Millions
Tenet Healthcare Corp  0.72 $ 22,154.000  Millions$ 30,787.000  Millions
Strata Critical Medical Inc   0.72 $ 236.425  Millions$ 328.668  Millions
Acadia Pharmaceuticals Inc   0.72 $ 1,202.301  Millions$ 1,676.619  Millions
Gossamer Bio Inc   0.71 $ 78.423  Millions$ 110.588  Millions
Quest Diagnostics Inc  0.71 $ 11,841.000  Millions$ 16,764.500  Millions
Mirum Pharmaceuticals Inc   0.71 $ 670.778  Millions$ 951.331  Millions
Ani Pharmaceuticals Inc  0.70 $ 1,041.343  Millions$ 1,481.030  Millions
3m Company  0.68 $ 25,247.000  Millions$ 36,904.750  Millions
Insmed Inc  0.68 $ 1,479.040  Millions$ 2,167.261  Millions
Illumina Inc   0.68 $ 4,538.000  Millions$ 6,666.250  Millions
Dentsply Sirona Inc   0.68 $ 3,575.000  Millions$ 5,263.000  Millions
Biomerica Inc   0.68 $ 4.338  Millions$ 6.413  Millions
Resmed Inc   0.67 $ 5,743.164  Millions$ 8,534.109  Millions
U S Physical Therapy Inc  0.67 $ 837.629  Millions$ 1,247.671  Millions
Eli Lilly And Company  0.67 $ 86,462.000  Millions$ 129,851.750  Millions
Bridgebio Pharma Inc   0.67 $ 945.540  Millions$ 1,421.523  Millions
Lantheus Holdings Inc   0.66 $ 1,561.890  Millions$ 2,361.195  Millions
Viskase Holdings inc   0.65 $ 271.837  Millions$ 420.742  Millions
Halozyme Therapeutics Inc   0.64 $ 1,802.448  Millions$ 2,812.199  Millions
Glaukos Corp  0.63 $ 578.355  Millions$ 921.716  Millions
Ceribell Inc   0.63 $ 109.203  Millions$ 174.150  Millions
Rhythm Pharmaceuticals Inc   0.62 $ 280.748  Millions$ 450.727  Millions
Sarepta Therapeutics Inc   0.61 $ 1,956.339  Millions$ 3,220.804  Millions
Heron Therapeutics Inc   0.61 $ 149.458  Millions$ 246.201  Millions
Intuitive Surgical Inc   0.60 $ 12,115.600  Millions$ 20,198.850  Millions
Supernus Pharmaceuticals inc   0.60 $ 865.106  Millions$ 1,444.793  Millions
Baxter International Inc   0.60 $ 11,784.000  Millions$ 19,776.500  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.